(SBSW) Sibanye Gold - Overview
Stock: Gold, PGMs, Chrome, Lithium, Nickel
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 81.4% |
| Relative Tail Risk | 0.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.34 |
| Alpha | 291.69 |
| Character TTM | |
|---|---|
| Beta | 1.074 |
| Beta Downside | 1.067 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.58% |
| CAGR/Max DD | 0.32 |
Description: SBSW Sibanye Gold January 08, 2026
Sibanye Stillwater Ltd (NYSE:SBSW) is a diversified precious-metals miner with operations spanning South Africa, the United States, Europe, and Australia. The firm extracts a broad suite of commodities-including gold, platinum-group metals (PGM) such as palladium and platinum, as well as chrome, lithium, zinc, nickel, silver, cobalt and copper-under a corporate structure formed in 2013 and headquartered in Weltevredenpark, South Africa.
Recent data (2023) show the company produced roughly 1.2 million ounces of gold and 1.0 million ounces of PGMs, while its lithium segment contributed about 15,000 tonnes of LCE, reflecting a strategic pivot toward battery metals. Cash costs per ounce of gold fell to $950, and the firm’s net debt stood at $1.1 billion, giving a debt-to-EBITDA ratio near 2.5×. Key drivers include global PGM demand from catalytic converters-subject to tightening emissions standards-and accelerating lithium demand from electric-vehicle battery supply chains.
For a deeper quantitative assessment, you may explore ValueRay’s analyst tools to evaluate SBSW’s valuation and risk profile.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -10.71b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.08 > 0.02 and ΔFCF/TA 3.93 > 1.0 |
| NWC/Revenue: 17.64% < 20% (prev 15.99%; Δ 1.65% < -1%) |
| CFO/TA 0.21 > 3% & CFO 29.81b > Net Income -10.71b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (707.6m) vs 12m ago -75.0% < -2% |
| Gross Margin: 18.23% > 18% (prev 0.10%; Δ 1814 % > 0.5%) |
| Asset Turnover: 160.1% > 50% (prev 124.4%; Δ 35.68% > 0%) |
| Interest Coverage Ratio: -6.98 > 6 (EBITDA TTM -291.0m / Interest Expense TTM 2.58b) |
Altman Z'' 0.96
| A: 0.27 (Total Current Assets 60.37b - Total Current Liabilities 20.90b) / Total Assets 144.70b |
| B: -0.12 (Retained Earnings -17.41b / Total Assets 144.70b) |
| C: -0.13 (EBIT TTM -17.98b / Avg Total Assets 139.81b) |
| D: 0.40 (Book Value of Equity 40.37b / Total Liabilities 100.35b) |
| Altman-Z'' Score: 0.96 = BB |
Beneish M -3.61
| DSRI: 0.90 (Receivables 10.72b/8.95b, Revenue 223.82b/167.84b) |
| GMI: 0.54 (GM 18.23% / 9.91%) |
| AQI: 0.94 (AQ_t 0.15 / AQ_t-1 0.16) |
| SGI: 1.33 (Revenue 223.82b / 167.84b) |
| TATA: -0.28 (NI -10.71b - CFO 29.81b) / TA 144.70b) |
| Beneish M-Score: -3.61 (Cap -4..+1) = AAA |
What is the price of SBSW shares?
Over the past week, the price has changed by -2.55%, over one month by +1.61%, over three months by +58.33% and over the past year by +311.25%.
Is SBSW a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SBSW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19 | 15.3% |
| Analysts Target Price | 19 | 15.3% |
| ValueRay Target Price | 18.4 | 11.7% |
SBSW Fundamental Data Overview February 07, 2026
P/E Forward = 6.035
P/S = 0.0989
P/B = 4.8257
Revenue TTM = 223.82b ZAR
EBIT TTM = -17.98b ZAR
EBITDA TTM = -291.0m ZAR
Long Term Debt = 42.14b ZAR (from longTermDebt, last quarter)
Short Term Debt = 460.0m ZAR (from shortTermDebt, last quarter)
Debt = 42.86b ZAR (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.85b ZAR (from netDebt column, last quarter)
Enterprise Value = 199.36b ZAR (177.51b + Debt 42.86b - CCE 21.01b)
Interest Coverage Ratio = -6.98 (Ebit TTM -17.98b / Interest Expense TTM 2.58b)
EV/FCF = -17.01x (Enterprise Value 199.36b / FCF TTM -11.72b)
FCF Yield = -5.88% (FCF TTM -11.72b / Enterprise Value 199.36b)
FCF Margin = -5.24% (FCF TTM -11.72b / Revenue TTM 223.82b)
Net Margin = -4.79% (Net Income TTM -10.71b / Revenue TTM 223.82b)
Gross Margin = 18.23% ((Revenue TTM 223.82b - Cost of Revenue TTM 183.01b) / Revenue TTM)
Gross Margin QoQ = 30.11% (prev 15.09%)
Tobins Q-Ratio = 1.38 (Enterprise Value 199.36b / Total Assets 144.70b)
Interest Expense / Debt = 3.17% (Interest Expense 1.36b / Debt 42.86b)
Taxrate = 21.0% (US default 21%)
NOPAT = -14.21b (EBIT -17.98b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.89 (Total Current Assets 60.37b / Total Current Liabilities 20.90b)
Debt / Equity = 1.06 (Debt 42.86b / totalStockholderEquity, last quarter 40.37b)
Debt / EBITDA = -75.07 (negative EBITDA) (Net Debt 21.85b / EBITDA -291.0m)
Debt / FCF = -1.86 (negative FCF - burning cash) (Net Debt 21.85b / FCF TTM -11.72b)
Total Stockholder Equity = 42.93b (last 4 quarters mean from totalStockholderEquity)
RoA = -7.66% (Net Income -10.71b / Total Assets 144.70b)
RoE = -24.95% (Net Income TTM -10.71b / Total Stockholder Equity 42.93b)
RoCE = -21.14% (EBIT -17.98b / Capital Employed (Equity 42.93b + L.T.Debt 42.14b))
RoIC = -17.10% (negative operating profit) (NOPAT -14.21b / Invested Capital 83.06b)
WACC = 8.44% (E(177.51b)/V(220.37b) * Re(9.87%) + D(42.86b)/V(220.37b) * Rd(3.17%) * (1-Tc(0.21)))
Discount Rate = 9.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.00%
Fair Price DCF = unknown (Cash Flow -11.72b)
EPS Correlation: -36.70 | EPS CAGR: 39.41% | SUE: 3.67 | # QB: 2
Revenue Correlation: -7.97 | Revenue CAGR: -11.36% | SUE: 1.11 | # QB: 3
EPS next Year (2026-12-31): EPS=44.90 | Chg30d=-2.844 | Revisions Net=-1 | Growth EPS=+192.7% | Growth Revenue=+33.1%